Sotera Health (SHC) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.26
- Estimate
- $0.24
- Surprise
- +8.7%
- Revenue (period 2026-06-30)
- $321.4M
- Score at report (before → after)
- 6.1 → 6.0/10
Revenue source: xbrl.
How the report landed
Sotera Health (SHC) beat the $0.24 estimate with diluted EPS of $0.26 — a clear 8.7% upside surprise. TrendMatrix's engine moved from Buy (Wait) (6.1/10) to Hold at 6.0/10 after the report — the engine's score fell despite the beat.
Where TrendMatrix's rating stands now
TrendMatrix currently rates SHC Sell at 6.0/10.
3 of the last 4 quarters beat the estimate; this quarter's +8.7% surprise compares with a +9.6% four-quarter average. Next scheduled report: 2026-11-03.
What supports the rating
- Strong earnings beat streak (3/4)
- High-quality business
What argues against it
- Concentration risk — Supplier: EO single supplier
- Analyst target reached - limited upside remaining
- Near 52-week high (1.4% away)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $19.57
- Price target
- $19.77
- Stop
- $18.47
- Upside to target
- +1.0%
- Reward-to-risk
- 0.1:1
The stock trades at 33.7× trailing but 18.2× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: RSI 73 — a level conventionally read as overbought; gains at these levels often lean on momentum.
Model outputs from TrendMatrix’s engine as of 2026-08-23 — shown for context, not personalized investment advice.
SHC at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Diagnostics & Research
- Market cap
- $5.58B
- P/E (fwd)
- 18.2
- P/E (ttm)
- 33.7
- 52-week range
- $13.09–$19.85
- Off 52-week high
- 1.4%
- RSI (14)
- 73
- Volume vs avg
- 0.74×
- Score today
- 6.0/10